Immunomodulatory fecal metabolites are associated with mortality in COVID-19 patients with respiratory failure.
Stutz MR, Dylla NP, Pearson SD, Lecompte-Osorio P, Nayak R, Khalid M, Adler E, Boissiere J, Lin H, Leiter W, Little J, Rose A, Moran D, Mullowney MW, Wolfe KS, Lehmann C, Odenwald M, De La Cruz M, Giurcanu M, Pohlman AS, Hall JB, Chaubard JL, Sundararajan A, Sidebottom A, Kress JP, Pamer EG, Patel BK.
Stutz MR, et al. Among authors: little j.
Nat Commun. 2022 Nov 3;13(1):6615. doi: 10.1038/s41467-022-34260-2.
Nat Commun. 2022.
PMID: 36329015
Free PMC article.